Pages that link to "Q38154151"
Jump to navigation
Jump to search
The following pages link to Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. (Q38154151):
Displaying 50 items.
- CpG Oligonucleotides as Cancer Vaccine Adjuvants (Q26783826) (← links)
- Antibody-based immunotherapy of solid cancers: progress and possibilities (Q26796542) (← links)
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications (Q26996518) (← links)
- The role of regulatory T cells in cancer immunology (Q27006663) (← links)
- Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors (Q28072532) (← links)
- Neoadjuvant anti-tumor vaccination prior to surgery enhances survival (Q34145877) (← links)
- Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008 (Q34306503) (← links)
- Targeting the tumor microenvironment to enhance antitumor immune responses (Q35176307) (← links)
- Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy (Q35216973) (← links)
- Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation. (Q36848243) (← links)
- Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma (Q37222152) (← links)
- A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma (Q37262109) (← links)
- PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer. (Q37352695) (← links)
- Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation (Q37615676) (← links)
- Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells. (Q37641651) (← links)
- Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways (Q37690959) (← links)
- Role of tumor microenvironment in tumorigenesis (Q37738074) (← links)
- Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy (Q38548889) (← links)
- The immunobiology of myeloid-derived suppressor cells in cancer (Q38649547) (← links)
- MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES. (Q38671001) (← links)
- Small cell lung cancer: Recruitment of macrophages by circulating tumor cells (Q38773484) (← links)
- Immune checkpoints and their inhibition in cancer and infectious diseases. (Q38845026) (← links)
- Frequent expression of PD-L1 on circulating breast cancer cells (Q38861829) (← links)
- Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors (Q38878888) (← links)
- Integrating liquid biopsies into the management of cancer (Q39157824) (← links)
- Immunomodulatory Nanomedicine (Q39224331) (← links)
- Dendritic Cell Therapies for Hematologic Malignancies (Q39289930) (← links)
- Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity (Q40253347) (← links)
- Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells (Q40309584) (← links)
- PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells (Q41057575) (← links)
- Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases (Q41265675) (← links)
- Tumor immune microenvironment characterization and response to anti-PD-1 therapy (Q41336719) (← links)
- Risk for cancer in living kidney donors and recipients (Q48194678) (← links)
- Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy (Q48508291) (← links)
- An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy (Q48533171) (← links)
- Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (Q49434203) (← links)
- A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy (Q50072990) (← links)
- Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer (Q51034587) (← links)
- Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model. (Q51453480) (← links)
- Liquid Biopsy in Head and Neck Cancer: Promises and Challenges. (Q52669514) (← links)
- Dural Cells Release Factors Which Promote Cancer Cell Malignancy and Induce Immunosuppressive Markers in Bone Marrow Myeloid Cells. (Q52692548) (← links)
- Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer. (Q53079766) (← links)
- Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy. (Q55511990) (← links)
- A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity (Q56889692) (← links)
- Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9 (Q58752133) (← links)
- Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model (Q59354898) (← links)
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape (Q61448458) (← links)
- Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model (Q86757302) (← links)
- Adaptive cancer treatment: why I put my money on immunotherapy (Q86942212) (← links)
- Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model (Q89861927) (← links)